Navigation Links
First comprehensive review of European breast cancer screening programs finds benefits outweigh harm
Date:9/12/2012

A major review of breast cancer screening services in Europe, jointly led by researchers at Queen Mary, University of London, has concluded that the benefits of screening in terms of lives saved outweigh the harms caused by over-diagnosis.

The results, which are published in a special supplement of The Journal of Medical Screening [1] today (Thursday), show that for every 1,000 women screened every two years from the age of 50 to the age of about 68-69, between seven and nine lives would be saved, and four cases would be over-diagnosed.

The European Screening Network (EUROSCREEN) working group [2], with members from nine European countries where outcome of screening programmes have been assessed, reviewed the estimates of benefit in published European studies in terms of breast cancer deaths prevented, and the major harms, in particular, the rates of what are called "over-diagnosed" cancers. These are breast cancers diagnosed as a result of screening, which would never have given rise to any symptoms during a woman's lifetime and would not have been diagnosed had she not been screened.

A second working group European Network for Indicators on Cancer (EUNICE) reviewed the organisation, participation rates and main performance parameters of 26 screening programmes in 18 countries, involving 12 million women, between 2001 and 2007 [3]. The reports from both working groups have contributed to the review published today.

Stephen Duffy, Professor of Cancer Screening at the Wolfson Institute of Preventive Medicine at Barts and The London School of Medicine & Dentistry, part of Queen Mary, University of London (UK), who is one of the coordinators of the EUROSCREEN working group and co-author of the supplement, said: "This is the only comprehensive review of the results of breast screening services in Europe. It reports results from screening millions of women, and confirms that the screening services are delivering the benefits expected from the research studies conducted years ago. In particular, it is good news that lives saved by screening outweigh over-diagnosed cases by a factor of two to one."

The researchers also found that for every 1,000 women screened, 170 women would have at least one recall followed by a non-invasive assessment before absence of cancer could be confirmed (a negative result), and 30 women would have at least one recall followed by invasive procedures, such as a biopsy, before confirming a negative result. Screening results that lead to recalls in these circumstances are called "false positives" and can cause women stress and anxiety until the negative result is confirmed.

Dr Eugenio Paci, Director of the Cancer Prevention and Research Institute in Florence, Italy, who is a second EUROSCREEN coordinator and co-author, said: "By weighing up the pros and cons of breast cancer screening programmes we hope to ensure that women are fully aware of the chief benefits and harms and can make a fully informed choice when they decide whether or not they wish to attend screening. There has been quite a lot of discussion recently over the worth of breast cancer screening and for this reason it is timely that the international group of experts has assessed the impact of population-based screening in Europe and has found that it is contributing to the reduction in deaths from the disease.

"We believe that not only should our conclusions be communicated to women offered breast screening in Europe, but that, in addition, communication methods should be improved in order to raise women's awareness, and to make information more accessible, relevant and comprehensible."


'/>"/>
Contact: Emma Mason
e.mason@qmul.ac.uk
Queen Mary, University of London
Source:Eurekalert

Related medicine news :

1. First pediatric study to look at the role of vitamin D in critical illness
2. Researchers find first evidence for a genetic cause for Barretts esophagus
3. London Olympics anti-doping labs set for first-of-a-kind repurposing
4. First validated method for analyzing flavanols and procyanidins in cocoa products could help scientists and the industry in standardized reporting
5. NIH scientists map first steps in flu antibody development
6. Likely voters say presidents first 100 days in office should include plans for research
7. First evidence from humans on how alcohol may boost risk of cancer
8. First identification of a strong oral carcinogen in smokeless tobacco
9. IHME professor named first health measurement winner of prestigious innovation award
10. FDA Gives Nod to First Drug for Diabetic Eye Disease
11. Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... With a ... medical and food industries. Aside from its GMP accreditation, Validation Center is also ... successfully certified products, services and staff. , Validation Center is ISO17025 accredited and ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways ... and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. ... say grilling is their favorite way to cook a hot dog, far outpacing other ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... Georgia (PRWEB) , ... May 26, 2016 , ... ... certificate in intellectual property (IP) to its specialty academic programs. , Answering to ... the college’s existing certificate programs in health law, and environmental and land use ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For Heroes ... lives in military battle for the country. The nonprofit Hope For Heroes partnered ... programs that empower independence for disabled military veterans, as well as police, firemen, and ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... York , May 26, 2016 ... Research "Medical Waste Management Market - U.S. Industry Analysis, Size, ... waste management market in the U.S. was valued at US$ ... a CAGR of 3.4% from 2015 to 2023 to reach ... exhaustive analysis of current and emerging needle free drug delivery ...
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
Breaking Medicine Technology: